Title : Cardiovascular risk profiles: A cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN-6 to the real-world type 2 diabetes population in the United Kingdom.

Pub. Date : 2022 Feb

PMID : 34668637






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Study findings remained consistent when restricted to GLP-1 RA users. Radium glucagon like peptide 1 receptor Homo sapiens